Abstract: Extracts of seventeen traditional Australian medicinal plants used to treat infections and respiratory conditions were tested for anti-mycobacterial activity against the fast-growing strains, Mycobacteriumfortuitum andM. smegmatis. Four extracts, the aerial parts of Pterocaulon sphacelatum (Asteraceae), the bark and leaves of Acacia ligulata (Mimosaceae), the leaves and stems of Eremophila alternifolia (Myoporaceae) and the leaves of Eremophila longifolia, showed activity against M. smegmatis only, while the two Eremophila extracts were also active against M. fortuitum. The minimum inhibitory concentrations ranged from 20-66 mg mL -1. The identification of the anti-mycobacterial compounds from these extracts may yield new and effective agents to combat diseases caused by Mycobacterium species.
INTRODUCTION

Tuberculosis (IB) is a serious respiratory infection and one of the most important diseases
worldwide. Epidemiological evidence indicates that one third of the world's population is infected with the causative bacterial agent, Mycobacterium tuberculosis, eight million cases emerge annually and about 2 million people die from the disease (Gautam et aI., 2007) . Recent data from the World Health Organization support these estimates with 8.8 million new TB cases and 1.6 million people deaths, including 195,000 patients infected with HIV, in 2005 (WHO, 2007 . By 2020, it has been estimated that nearly 1 billion people will become infected, 200 million will develop disease and 35 million will die from TB, although recent figures suggest that the global epidemic is on the threshold of decline (WHO, 2007) . However, the emergence and spread of drug-resistant M. tuberculosis, especially multi drug-resistant (MDR) strains resistant to standard TB drugs such as isoniazid and rifampin, reduces the efficacy of current treatment regimes and threatens programs aimed at controlling TB (Sacchettini et al., 2008) . Drug-resistant TB is caused by a number of factors including slow-acting drugs and inadequate health-care systems, leading to poor compliance, incomplete treatment and relapse (Sacchettini et aI., 2008) . Treatment of MDR-TB requires the use of at least t hree drugs not prescribed previously to the patient and in some cases four or more anti-TB agents are necessary.
Nevertheless, not all cases are cured. As a result, there is an urgent need for potent new drugs to deal properly wit h cases of MDR-TB. Moreover, t he increasing occurrence of infections caused by other species of Mycobac terium is of additional concern (Bodle et al., 2008) . Semple, 2001, 2002; N di et aI., 2007 a) . However, this is the first study to demonstrate activity against species of Mycobacterium. The antibacterial activity of an extract of Eremophila duttonii against Staphylococcus aureus was shown to be the result of increased cell permeability due to cell membrane damage (Tomlinson and Palombo, 2005) while the antimicrobial constituents of some Eremophila species have recently been identified as o-naphthoquinones and serrulatane diterpenoids (Ndi et aI., 2007b, c; Smith et aI., 2007) . Since terpenoids exert their antimicrobial activity by destabilization and permeabilization of bacterial membranes (Smith et aI., 2007) , it would be of interest to determine if the active extracts identified in this study exert similar damage to the mycobacterial cell membrane. There are limited reports of traditional uses of Australian plants in the treatment of TB (Lassak and McCarthy, 2001) , although specific activity against bacteria has not been determined. The present study is the first extensive screening of Australian medicinal Res. J. Microbio!., 3 (7): [535] [536] [537] [538] 2008 plants for anti-mycobacterial activity and it provides scientific evidence of specific activity that supports the traditional use of plants to treat respiratory illness. However, additional testing against the respiratory pathogen, M. tuberculosis, is needed to confirm that the observed activity extends to this species. Future research will also aim to determine the active compounds in t hese extracts.
